889 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Acquired by Optivise Advisory Services LLC

Optivise Advisory Services LLC acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the third quarter, Holdings Channel reports. The institutional investor acquired 889 shares of the healthcare conglomerate’s stock, valued at approximately $520,000.

Other large investors have also recently added to or reduced their stakes in the company. Kathleen S. Wright Associates Inc. bought a new stake in UnitedHealth Group during the third quarter worth approximately $27,000. Macroview Investment Management LLC boosted its position in shares of UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after acquiring an additional 47 shares during the period. Bbjs Financial Advisors LLC bought a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $31,000. Global Wealth Strategies & Associates boosted its position in shares of UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 32 shares during the period. Finally, Signature Resources Capital Management LLC boosted its position in shares of UnitedHealth Group by 40.0% in the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 18 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $590.77 on Friday. The stock has a 50-day moving average price of $582.63 and a 200 day moving average price of $552.59. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market cap of $543.67 billion, a price-to-earnings ratio of 38.49, a PEG ratio of 1.75 and a beta of 0.58. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter last year, the business earned $6.56 earnings per share. The company’s revenue was up 9.2% compared to the same quarter last year. Research analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.

Analysts Set New Price Targets

Several brokerages recently commented on UNH. Royal Bank of Canada reduced their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. HSBC cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. TD Cowen raised their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. KeyCorp initiated coverage on UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 target price for the company. Finally, Barclays dropped their price objective on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.